These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30668208)

  • 1. Changes in premenstrual symptoms in women starting or discontinuing use of oral contraceptives.
    Ekenros L; Bäckström T; Hirschberg AL; Fridén C
    Gynecol Endocrinol; 2019 May; 35(5):422-426. PubMed ID: 30668208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between mood and sexuality in women using an oral contraceptive as a treatment for premenstrual symptoms.
    Graham CA; Sherwin BB
    Psychoneuroendocrinology; 1993; 18(4):273-81. PubMed ID: 8316616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prefrontal GABA concentration changes in women-Influence of menstrual cycle phase, hormonal contraceptive use, and correlation with premenstrual symptoms.
    De Bondt T; De Belder F; Vanhevel F; Jacquemyn Y; Parizel PM
    Brain Res; 2015 Feb; 1597():129-38. PubMed ID: 25481417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive.
    London RS; Chapdelaine A; Upmalis D; Olson W; Smith J
    Acta Obstet Gynecol Scand Suppl; 1992; 156():9-14. PubMed ID: 1324557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of resting state networks in the female brain during hormonal changes and their relation to premenstrual symptoms.
    De Bondt T; Smeets D; Pullens P; Van Hecke W; Jacquemyn Y; Parizel PM
    Brain Res; 2015 Oct; 1624():275-285. PubMed ID: 26253822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraception and cyclic changes in premenstrual and menstrual experiences.
    Abraham S; Luscombe G; Soo I
    J Psychosom Obstet Gynaecol; 2003 Sep; 24(3):185-93. PubMed ID: 14584305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy.
    Lussier-Cacan S; Xhignesse M; Desmarais JL; Davignon J; Kafrissen ME; Chapdelaine A
    Metabolism; 1991 Aug; 40(8):849-54. PubMed ID: 1907348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG; Steffens D; Schramm G
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL; Katz M
    Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mood changes during the menstrual cycle and their relation to the use of oral contraceptive.
    Almagor M; Ben-Porath YS
    J Psychosom Res; 1991; 35(6):721-8. PubMed ID: 1791586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of continuous versus cyclical oral contraception: a randomized controlled trial.
    Legro RS; Pauli JG; Kunselman AR; Meadows JW; Kesner JS; Zaino RJ; Demers LM; Gnatuk CL; Dodson WC
    J Clin Endocrinol Metab; 2008 Feb; 93(2):420-9. PubMed ID: 18056769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility of hormone-driven regional grey matter volume changes in women using SPM8 and SPM12.
    De Bondt T; Pullens P; Van Hecke W; Jacquemyn Y; Parizel PM
    Brain Struct Funct; 2016 Dec; 221(9):4631-4641. PubMed ID: 26862108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between symptom severity and hormone changes in women with premenstrual syndrome.
    Hammarbäck S; Damber JE; Bäckström T
    J Clin Endocrinol Metab; 1989 Jan; 68(1):125-30. PubMed ID: 2491857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of oral contraceptives on integrated secretion of gonadotropins.
    Dericks-Tan JS; Gudacker V; Taubert HD
    Contraception; 1992 Oct; 46(4):369-77. PubMed ID: 1486775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex hormone profiles in oligomenorrheic adolescent girls and the effect of oral contraceptives.
    Siegberg R; Nilsson CG; Stenman UH; Widholm O
    Fertil Steril; 1984 Jun; 41(6):888-93. PubMed ID: 6233177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in physiological, EEG and psychological parameters in women during the spontaneous menstrual cycle and following oral contraceptives.
    Becker D; Creutzfeldt OD; Schwibbe M; Wuttke W
    Psychoneuroendocrinology; 1982; 7(1):75-90. PubMed ID: 7100370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
    Letterie GS
    Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.
    Graham CA; Sherwin BB
    J Psychosom Res; 1992 Apr; 36(3):257-66. PubMed ID: 1564678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporary increase of FSH levels in healthy, nulliparous, young women after cessation of low-dose oral contraceptive use.
    Jernstrom H; Knutsson M; Olsson H
    Contraception; 1995 Jul; 52(1):51-6. PubMed ID: 8521715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
    Greene KE; Kettel LM; Yen SS
    Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.